Connect with us

JAMMU & KASHMIR

Plasma Therapy yielding good results, more than 100 patients received plasma at SKIMS | KNO

Dir SKIMS appreciates donors for saving lives

Published

on

kno news

Srinagar, Aug 12 (KNO): Over 100 COVID-19 patients have so far received Convalescent Plasma therapy at Sheri-Kashmir Institute of Medical Sciences, an official handout said. Director SKIMS Dr. A.G Ahangar as per a statement issued to the new agency—Kashmir News Observer (KNO) thanked people for immense support and their overwhelming response for donating plasma to save COVID sick patients. While lauding the efforts of the Plasma Therapy team, he said that SKIMS achieved a milestone in the treatment of patients with COVID-19 where hundred patients have received plasma therapy so far. “Plasma therapy is being worked out as a treatment modality for moderate to severely sick patients with COVID-19. In UT of J&K, the Apex Committee for COVID-19 had recommended plasma therapy for COVID-19 patients and issued guidelines for it. It has yielded satisfying results throughout the world and has been tried across the country,” he added.  Director SKIMS & Ex-Officio Secretary to Government, Prof. A. G. Ahangar had appealed to those who recovered from COVID-19 for plasma donation. “People responded with enthusiasm as voluntary donation for convalescent plasma is happening at a great pace. People from all walks of life are volunteering for donation even amid lockdown. The donors also include 30 doctors and paramedics who donated plasma so far,” he added. Director SKIMS thanked donors and has directed to issue “Certificate of Appreciation” to those warriors for coming to the help of humanity at this crucial hour. H.O.D. of Blood Transfusion & Immunohaematology, Dr. Romana Makhdoomi while giving details said that SKIMS started Plasma Therapy in the month of June with installation of sophisticated and of State-of-Art Apheresis-machine to carry out the procedure with precision and more than 100 COVID positive patients received plasma and benefitted and no transfusion related complications have been reported from all those who have received the therapy. “Though the detailed studies for evaluating the effectiveness of convalescent plasma on patients with COVID-19 are underway, preliminary reporting suggests that many patients have benefitted from the treatment. The procedure is available 24X7 in Blood Transfusion & Immunohematology, SKIMS and the department has a dedicated helpline for helping out the donors and recipients alike,” Dr Makhdoomi said—(KNO) 

Copyright © 2020